Range
6.87 - 7.83
Vol / Avg.
1.7M/3.4M
Div / Yield
-
52 Wk
3.4 - 9.46
Mkt Cap
501.9M
Payout Ratio
-
Open
7.12
P/E
-
EPS
-0.25
Shares
66.1M
Outstanding
66.1M
Total Float
56.9M
Benzinga - May 6, 2021, 7:34AM
Benzinga - May 4, 2021, 9:35AM
Benzinga - May 4, 2021, 7:49AM
Benzinga - May 4, 2021, 7:22AM
Benzinga - May 3, 2021, 9:31AM
Benzinga - Apr 23, 2021, 7:02AM
Benzinga - Apr 13, 2021, 4:16PM
Benzinga - Apr 5, 2021, 3:42PM
Benzinga - Mar 31, 2021, 7:23AM
Benzinga - Mar 30, 2021, 4:16PM
Benzinga - Mar 30, 2021, 4:15PM
Benzinga - Mar 25, 2021, 11:47AM
Benzinga - Mar 25, 2021, 11:42AM
Benzinga - Mar 25, 2021, 10:44AM
Benzinga - Mar 24, 2021, 8:16AM
Benzinga - Mar 24, 2021, 7:03AM
Benzinga - Mar 17, 2021, 7:16AM
Benzinga - Mar 2, 2021, 4:34PM
Benzinga - Feb 25, 2021, 7:21AM
Benzinga - Jan 26, 2021, 2:19PM
load more
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.290-0.300 -0.0100
REV570.000K170.032K-399.968K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PRQRProQR Therapeutics5.56%501.9M

ProQR Therapeutics Frequently Asked Questions

Q

How do I buy ProQR Therapeutics (PRQR) stock?

A

You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ProQR Therapeutics's (PRQR) competitors?

A

There are no as such competitors for ProQR Therapeutics.

Q

What is the target price for ProQR Therapeutics (PRQR) stock?

A

The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Stifel on May 3, 2021. The analyst firm set a price target for 20.00 expecting PRQR to rise to within 12 months (a possible 163.50% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ProQR Therapeutics (PRQR)?

A

The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $7.59 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does ProQR Therapeutics (PRQR) pay a dividend?

A

There are no upcoming dividends for ProQR Therapeutics.

Q

When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?

A
ProQR Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is ProQR Therapeutics (PRQR) going to split?

A

There is no upcoming split for ProQR Therapeutics.

Q

What sector and industry does ProQR Therapeutics (PRQR) operate in?

A

ProQR Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.